A Phase II Study Evaluating the Effect of GEN-1 on SLL When Administered in Combination With Bevacizumab and NACT in Subjects Newly Diagnosed With Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Cancer Interventions:   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab;   Drug: GEN1 Sponsors:   Imunon;   Break Through Cancer Foundation Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials